Serial immunomonitoring of cancer patients receiving combined antagonistic anti-CD40 and chemotherapy reveals consistent and cyclical modulation of T cell and dendritic cell parameters

Overview of attention for article published in BMC Cancer, June 2017

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)
Good Attention Score compared to outputs of the same age and source (73rd percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 14,246 followers.

RT @perth_meso_dr: The difficult task of immunomonitoring during chemo-immunotherapy (anti-CD40) - our new publication in BMC Cancer: https…

RT @perth_meso_dr: The difficult task of immunomonitoring during chemo-immunotherapy (anti-CD40) - our new publication in BMC Cancer: https…

RT @perth_meso_dr: The difficult task of immunomonitoring during chemo-immunotherapy (anti-CD40) - our new publication in BMC Cancer: https…

RT @perth_meso_dr: The difficult task of immunomonitoring during chemo-immunotherapy (anti-CD40) - our new publication in BMC Cancer: https…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.